How to Buy Ars Pharmaceuticals Stock
Ars Pharmaceuticals Inc
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites.
Ars Pharmaceuticals stock last closed at $9.24, up 2.44% from the previous day, and has increased 42.37% in one year. It has overperformed other stocks in the Biotechnology industry by 0.66 percentage points. Ars Pharmaceuticals stock is currently +262.35% from its 52-week low of $2.55, and -18.01% from its 52-week high of $11.27.
At the moment, there are 96.5M SPRY shares outstanding. The market value of SPRY is $891.67M. In the past 24 hours, 459,613 SPRY shares were traded.
How to Buy Ars Pharmaceuticals Stock
Wondering how to invest in Ars Pharmaceuticals stock? Here's how.
- Choose where to buy Ars Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Ars Pharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your payment method and add your details.
- Research Ars Pharmaceuticals stock: The Ars Pharmaceuticals ticker symbol is SPRY. Is Ars Pharmaceuticals stock a good investment? Should you buy shares of SPRY? How do SPRY's underlying business fundamentals look? Do top analysts think Ars Pharmaceuticals is a good buy? Why has SPRY's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if SPRY is a good stock to buy).
- Make your SPRY purchase: Decide if you will purchase SPRY shares at the current market price or use a limit order to buy SPRY shares at a given price.
- Keep tabs on your investment in SPRY: Create a watchlist to important updates regarding your investment in Ars Pharmaceuticals shares.
Step 1: Choose where to buy Ars Pharmaceuticals stock
You need a brokerage account to access the NASDAQ market and buy SPRY stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal info so you can invest in SPRY today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have filled out your info on app for stock market, you need to deposit funds:
Watch the video below for more details depositing funds into your new brokerage account.
Step 4: Research Ars Pharmaceuticals stock
Once you have decided on the best place to buy Ars Pharmaceuticals stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk and upside.
Overview of key SPRY info
SPRY Zen Score
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SPRY's stock page.
Is SPRY stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge SPRY's intrinsic value.
Using relative valuations metrics:
- SPRY could be undervalued based on its P/B ratio of 3.86x, relative to Biotechnology industry P/B ratio of 5.88x
You can access more valuation analysis on SPRY's stock here.
SPRY Financial Health
Passed Financial Due Diligence Checks:
- SPRY has cash burn of 59441000. It has enough cash and short-term investments to cover this for at least one year.
- SPRY has $228.36M in cash and short term investments. This is sufficient to cover its annual cash burn of $59.44M.
- There are more short-term assets than short-term liabilities on the SPRY balance sheet.
- SPRY has a low debt to equity ratio of 0.01.
- There are more short-term assets than long-term liabilities on the SPRY balance sheet.
- Total SPRY debt is lower than 5 years ago, relative to shareholder equity.
Failed Financial Due Diligence Checks:
- SPRY profit margin has gone down from -2,635.4% to -181,216.7% in the past year.
Is Ars Pharmaceuticals stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 sell side analysts who monitor SPRY, the consensus analyst rating on SPRY is a Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Ars Pharmaceuticals stock forecast page.
SPRY Trading Indicators
Is SPRY Making Money?
Last year, SPRY revenue was $30.00k. Over the past two year, SPRY's revenue has grown by -92.62% per year. This was slower than the Biotechnology industry average of 29.04%.
You can research SPRY's earnings and revenue performance here.
What are SPRY insiders up to?
Over the last year, executives and large shareholders at SPRY have bought more shares than they have sold.
Richard E. Lowenthal, PRESIDENT AND CEO of SPRY, was the latest SPRY insider to sell. They sold $463,850.00 worth of SPRY shares on Apr 9, 2024.
Dig into more about who owns SPRY shares here.
Can I rely on SPRY as an income stream?
No, Ars Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about SPRY?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your SPRY purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price limit, use a limit order.
Click the Open button and your broker will place the order.
If you need more help with buying stocks on eToro, click the how to video below:
Step 6: Keep tabs on your investment in SPRY
Now that you own some SPRY shares, you'll want to stay up-to-date on your new company.
Add SPRY to a watchlist to track your SPRY stock.
SPRY Feed
How to Buy Stock in Ars Pharmaceuticals
To summarize, here are the 6 steps for buying Ars Pharmaceuticals stock:
- Choose where to buy Ars Pharmaceuticals stock
- Open your brokerage account
- Fund your investment account
- Research Ars Pharmaceuticals stock
- Make your SPRY purchase
- Keep tabs on your investment in SPRY
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Ars Pharmaceuticals, get started below.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.